Advisor Partners LLC increased its position in Humana Inc. (NYSE:HUM) by 11.3% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 3,341 shares of the insurance provider’s stock after buying an additional 339 shares during the period. Advisor Partners LLC’s holdings in Humana were worth $804,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. BlackRock Inc. boosted its position in Humana by 2,281.7% in the first quarter. BlackRock Inc. now owns 12,387,144 shares of the insurance provider’s stock valued at $2,553,487,000 after buying an additional 11,867,056 shares during the period. Vanguard Group Inc. boosted its position in Humana by 3.6% in the first quarter. Vanguard Group Inc. now owns 9,734,767 shares of the insurance provider’s stock valued at $2,006,725,000 after buying an additional 339,620 shares during the period. State Street Corp boosted its position in Humana by 1.4% in the first quarter. State Street Corp now owns 6,274,811 shares of the insurance provider’s stock valued at $1,293,487,000 after buying an additional 84,716 shares during the period. FMR LLC boosted its position in Humana by 57.9% in the first quarter. FMR LLC now owns 5,050,853 shares of the insurance provider’s stock valued at $1,041,184,000 after buying an additional 1,851,197 shares during the period. Finally, Renaissance Technologies LLC boosted its position in Humana by 84.3% in the first quarter. Renaissance Technologies LLC now owns 2,691,700 shares of the insurance provider’s stock valued at $554,867,000 after buying an additional 1,231,400 shares during the period. 99.66% of the stock is currently owned by hedge funds and other institutional investors.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $3.08 by $0.41. The business had revenue of $13.53 billion during the quarter, compared to the consensus estimate of $13.61 billion. Humana had a return on equity of 15.85% and a net margin of 3.37%. During the same period last year, the company earned $2.30 earnings per share.

TRADEMARK VIOLATION WARNING: “Advisor Partners LLC Has $804,000 Stake in Humana Inc. (NYSE:HUM)” was published by Daily Political and is the property of of Daily Political. If you are reading this piece of content on another domain, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this piece of content can be read at https://www.dailypolitical.com/2017/08/07/advisor-partners-llc-has-804000-stake-in-humana-inc-nysehum.html.

Several equities analysts have weighed in on the company. Zacks Investment Research raised Humana from a “hold” rating to a “buy” rating and set a $253.00 target price on the stock in a research note on Thursday, May 18th. BidaskClub cut Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, June 13th. Citigroup Inc. assumed coverage on Humana in a research note on Wednesday, June 28th. They set a “buy” rating and a $275.00 target price on the stock. Credit Suisse Group reaffirmed an “outperform” rating and set a $260.00 target price (up previously from $250.00) on shares of Humana in a research note on Thursday. Finally, Oppenheimer Holdings, Inc. lifted their target price on Humana from $236.00 to $255.00 and gave the company an “outperform” rating in a research note on Thursday. Two research analysts have rated the stock with a sell rating, eight have given a hold rating and twelve have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $241.65.

In related news, SVP Brian P. Leclaire sold 4,971 shares of the stock in a transaction dated Wednesday, June 28th. The stock was sold at an average price of $240.00, for a total transaction of $1,193,040.00. Following the completion of the transaction, the senior vice president now directly owns 14,258 shares in the company, valued at $3,421,920. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, VP Heidi S. Margulis sold 1,500 shares of the stock in a transaction dated Friday, May 26th. The stock was sold at an average price of $231.96, for a total value of $347,940.00. Following the transaction, the vice president now owns 8,150 shares of the company’s stock, valued at $1,890,474. The disclosure for this sale can be found here. 0.80% of the stock is currently owned by company insiders.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.